Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome

References

1. ↵
   von Kummer R, Holle R, Rosin L, et al. Does arterial recanalization improve outcome in carotid territory stroke? Stroke 1995;26:581–587

   Abstract/FREE Full Text
2. ↵
   Alvarez-Sabin J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003;34:1235–1241

   Abstract/FREE Full Text
3. Labiche LA, Al-Senani F, Wojner AW, et al. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003;34:695–698

   Abstract/FREE Full Text
4. ↵
   Molina CA, Alexandrov AV, Demchuk AM, et al. CLOTBUST Investigators: improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151–156

   Abstract/FREE Full Text
5. ↵
   Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol 1990;47:1245–1254

   CrossRefPubMedWeb of Science
6. ↵
   Kirchhof K, Sikinger M, Welzel T, et al [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?] Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2004;176:98–105

   CrossRefPubMed
7. ↵
   Zaidat OO, Suarez JI, Santillan C. Intrarterial and combined intravenouns and intra-arterial thrombolytic therapy for distal carotid artery occlusion. Stroke 2002;33:1828–1833

   Abstract/FREE Full Text
8. ↵
   Furlan A, Higashida R, Weschler L, et al., for the PROACT II Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: a randomized controlled trial. JAMA 1999;282:2003–2011

   CrossRefPubMedWeb of Science
9. Zaidat OO, Welter E, Love TE, et al. Combined intra-venous and intra-arterial versus intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke patients: propensity score analysis. J Neurosurg 2004;100:A181 [abstract]
10. ↵
    Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109–114

    Abstract/FREE Full Text
11. ↵
    Demchuk AM, Burgin WS, Christou I, et al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89–93

    Abstract/FREE Full Text
12. ↵
    IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904–911

    Abstract/FREE Full Text
13. ↵
    National Institute of Neurological Disorders and the Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587

    CrossRefPubMedWeb of Science
14. Kim JJ, Fischbein NJ, Lu Y, et al. Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 2004;35:1340–1344

    Abstract/FREE Full Text
15. ↵
    Kent TA, Soukup VM, Fabian RH. Heterogeneity affecting outcome from acute stroke therapy: making reperfusion worse. Stroke 2001;32:2318–2327

    Abstract/FREE Full Text
16. ↵
    NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28:2119–2125

    Abstract/FREE Full Text
17. ↵
    Kirmani JF, Safdar A, Siddiqui AM, et al. Correlation of rates of re-canalization to the thromboembolic source in acute stroke thrombolytic therapy. J Neurosurg 2004;100:A189 [abstract]
18. ↵
    Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activetor: the rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3–13

    Abstract/FREE Full Text
19. ↵
    MERCI Investigators. Results of the combined MERCI I–II (Mechanical Embolus Removal in Cerebral Ischemia) trials. Stroke 2004;35:240 [abstract]
20. ↵
    Berlis A, Lutsep H, Barnwell S, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004;35:1112–1116

    Abstract/FREE Full Text
21. ↵
    Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319–1327; discussion 1327–1329

    PubMedWeb of Science
22. ↵
    Provenzale JM, Jahan R, Naidich TP, Fox AJ. Assessment of the patient with hyperacute stroke: imaging and therapy. Radiology 2003;229:347–359

    PubMedWeb of Science